In response to the European Fee, most cancers is on the rise within the EU, with the variety of new instances reaching 2.7 million in 2022. Most cancers deaths for that very same yr additionally went up and had been estimated to be at 1.3 million.
Particularly, pancreatic most cancers remained the main reason for cancer-related deaths within the EU in 2022. Though this most cancers has a decrease incidence than many others (it ranks 8th amongst males and 5th amongst ladies), its low survival fee locations it among the many prime 4 deadliest cancers in each women and men.
Since 2020, the ULISES Consortium has been working laborious to develop a brand new remedy to battle pancreatic most cancers by way of nanoparticles. The main target of this mission is to get a affected person’s immune system to reject the tumor. Its progressive technique primarily consists of delivering genetic materials to the tumor cells to make them seen to the immune system, thus triggering a response akin to the vaccine impact. Nanoparticles play a vital function on this. As soon as synthesized, they bear a putting resemblance to these used for the COVID-19 vaccine. As solely tumor cells are focused, this new remedy would additionally keep away from a lot of the opposed reactions of present therapies, akin to chemo- and radiotherapy.
Furthermore, if this remedy proves efficient, it might not solely present a treatment for one of many deadliest cancers on this planet, pancreatic most cancers but additionally open up a brand new therapeutic alternative for different varieties of lethal tumors that presently haven’t any treatment choices.
To be taught extra in regards to the mission, watch our Video Information Launch.
Nanoparticles and main improvements: preventing most cancers by way of the immune system
This Video Information Launch was produced by Diego Giuliani, ICONS editorial supervisor
